2018 20181030gui By feedproxy.google.com Published On :: 2018-10-30T15:27:00Z Topics in this issue include: Support for Non-Consecutive Month CSOs - November 18 New Price Precision Extension - 2018 New - Support for Non-Consecutive Month CSOs Effective Sunday, November 18 (trade date Monday, November 19), to simplify the submission of trade entry reports, CME ClearPort will support trade entry for Calendar Spread Options (CSOs) on products, typically Agricultural, that do not list consecutive monthly contracts. This enhancement will be available in New Release for customer testing on Wednesday, November 7. Back to Top Price Precision Extension CME Group is implementing end-to-end technology changes to support increased price granularity. Currently, CME Group systems support a maximum of 7 decimals. With this initiative, products with up to 9 decimals may be listed and traded. Effective Sunday, January 13 (trade date Monday, January 14), pending regulatory approval, the 2 Year Treasury Note futures and spreads will move from 7 decimals to 8 to support trading at 1/8 of 1/32. Customers are encouraged to move to support 9 decimals now; but there are no plans to list a product that uses the 9th decimal at this time. For more on impacted products and CME Globex, iLink messaging, Drop Copy and Market Data impacts, view the CME Globex Client Impact Assessment. These enhancements are currently available for testing in New Release. Back to Top Full Article
2018 20181031 By feedproxy.google.com Published On :: 2018-10-31T14:20:36Z The CME ClearPort enhancement for non-consecutive Calendar Spread Options (CSOs) has been postponed. The new launch date will be announced in future CME ClearPort Notices. Full Article
2018 20181113api By feedproxy.google.com Published On :: 2018-11-13T20:00:00Z Topics in this issue include: Support for Additional Calendar Spread Options - December 2 New Price Precision Extension - 2018 New - Support for Additional Calendar Spread Options Effective Sunday, December 2 (trade date Monday, December 3), pending all relevant CFTC regulatory review periods, CME ClearPort will support trade entry for the following Calendar Spread Options (CSOs): Consecutive Corn CSO Consecutive Soybean CSO Consecutive Soybean Oil CSO Consecutive Chicago SRW Wheat CSO Consecutive Soybean Meal CSO Consecutive KC HRW CSO For more information, please refer to SER-8279 in the Special Executive Report (SER) Notice Archive. This enhancement will be available for customer testing in New Release on Wednesday, November 14. Back to Top Price Precision Extension CME Group is implementing end-to-end technology changes to support increased price granularity. Currently, CME Group systems support a maximum of 7 decimals. With this initiative, products with up to 9 decimals may be listed and traded. Effective Sunday, January 13, 2019 (trade date Monday, January 14), pending regulatory approval, the 2 Year Treasury Note futures and spreads will move from 7 decimals to 8 to support trading at 1/8 of 1/32. Customers are encouraged to move to support 9 decimals now; but there are no plans to list a product that uses the 9th decimal at this time. The attributes listed below will be impacted. For more on impacted products and CME Globex, iLink messaging, Drop Copy and Market Data impacts, view the CME Globex Client Impact Assessment. Trade Capture Reports and Acknowledgements Price will be impacted at the Trade Capture Report and Trade Instrument Leg Group levels. Level Field Name FIXML Attribute Name /TrdCaptRpt - inbound Trade Price LastPx /TrdCaptRpt/TrdLeg - inbound Leg Last Price LastPx /TrdCaptRptAck - outbound Trade Price LastPx /TrdCaptRptAck/TrdLeg - outbound Leg Last Price LastPx /TrdCaptRpt - outbound Trade Price LastPx /TrdCaptRpt/TrdLeg - outbound Leg Last Price LastPx Reference Data Level Field Name FIXML Attribute Name /SecDef/Instrmt MinPriceIncrement MinPxIncr /DerivSecList/DerivSecDef/DerivInstrmt MinPriceIncrement MinPxIncr These enhancements are currently available for customer testing in New Release. Back to Top Full Article
2018 20181206 By feedproxy.google.com Published On :: 2018-12-06T14:27:00Z Today, CME Group launched CME Reference Data API, a real-time solution for accessing information on every instrument and product at CME Group. Embed the CME Reference Data API in your system’s product matrices and databases to automate product reference data for all CME Group and hosted partner exchange markets. CME Reference Data API includes: Contract specifications Product codes and symbols Trade and order type eligibility Instrument lifecycle dates: first and last trade date, notices, delivery and settlement Key Benefits: Reduce the risk of errors with automated definitions Machine-readable API delivers product and instrument information without human intervention Access CME Group markets and products faster A cost-effective solution to accessing product data Request Access: Contact Global Account Management to obtain access to the Reference Data API: U.S.: +1 312 634 8700 Europe: +44 20 3379 3754 Asia: +65 6593 5505 Additional Resources: CME Reference Data API Specifications CME Reference Data API webpage Subscribe to receive notices about the latest technology updates for Reference Data API. Full Article
2018 20181219api By feedproxy.google.com Published On :: 2018-12-19T20:00:00Z Topics in this issue include: CME Reference Data API Launch - Available Price Precision Extension - Janaury 13, 2019 CME Reference Data API Launch CME Group has launched CME Reference Data API, a real-time solution for accessing information on every instrument and product at CME Group. Embed the CME Reference Data API in your system’s product matrices and databases to automate product reference data for all CME Group and hosted partner exchange markets. CME Reference Data API includes: Contract specifications Product codes and symbols Trade and order type eligibility Instrument life cycle dates: first and last trade date, notices, delivery and settlement Key Benefits: Reduce the risk of errors with automated definitions Machine-readable API delivers product and instrument information without human intervention Access CME Group markets and products faster A cost-effective solution to accessing product data Request Access: Contact Global Account Management to obtain access to the Reference Data API: U.S.: +1 312 634 8700 Europe: +44 20 3379 3754 Asia: +65 6593 5505 Additional Resources: CME Reference Data API Specifications CME Reference Data API webpage Subscribe to receive notices about the latest technology updates for Reference Data API. Back to Top Price Precision Extension CME Group is implementing end-to-end technology changes to support increased price granularity. Currently, CME Group systems support a maximum of 7 decimals. With this initiative, products with up to 9 decimals may be listed and traded. Effective Sunday, January 13, 2019 (trade date Monday, January 14), pending regulatory approval, the 2 Year Treasury Note futures and spreads will move from 7 decimals to 8 to support trading at 1/8 of 1/32. Customers are encouraged to move to support 9 decimals now; but there are no plans to list a product that uses the 9th decimal at this time. The attributes listed below will be impacted. For more on impacted products and CME Globex, iLink messaging, Drop Copy and Market Data impacts, view the CME Globex Client Impact Assessment. Trade Capture Reports and Acknowledgements Price will be impacted at the Trade Capture Report and Trade Instrument Leg Group levels. Level Field Name FIXML Attribute Name /TrdCaptRpt - inbound Trade Price LastPx /TrdCaptRpt/TrdLeg - inbound Leg Last Price LastPx /TrdCaptRptAck - outbound Trade Price LastPx /TrdCaptRptAck/TrdLeg - outbound Leg Last Price LastPx /TrdCaptRpt - outbound Trade Price LastPx /TrdCaptRpt/TrdLeg - outbound Leg Last Price LastPx Reference Data Level Field Name FIXML Attribute Name /SecDef/Instrmt MinPriceIncrement MinPxIncr /DerivSecList/DerivSecDef/DerivInstrmt MinPriceIncrement MinPxIncr These enhancements are currently available for customer testing in New Release. Back to Top Full Article
2018 BIZ-Quartalsbericht, März 2018 By www.bis.org Published On :: 2018-03-11T17:00:00Z German translation of the BIS Quarterly Review, March 2018 Full Article
2018 BIZ-Quartalsbericht März 2018: Volatilität rückt nach Aktienmarktturbulenzen erneut in den Fokus By www.bis.org Published On :: 2018-03-11T17:00:00Z German translation of the BIS press release about the BIS Quarterly Review, March 2018 Full Article
2018 BIZ-Quartalsbericht, Juni 2018 By www.bis.org Published On :: 2018-06-05T10:00:00Z German translation of the BIS Quarterly Review, June 2018 Full Article
2018 Wirtschaftsbericht 2018 By www.bis.org Published On :: 2018-06-24T10:30:00Z German translation of the Annual Economic Report 2018 of the BIS, June 2018 - Die politischen Entscheidungsträger können dem gegenwärtigen Wirtschaftsaufschwung eine nachhaltige Basis verleihen, schreibt die BIZ in ihrem Wirtschaftsbericht. Dazu sollten sie strukturpolitische Maßnahmen ergreifen, mit Blick auf künftige Risiken wieder für größeren Handlungsspielraum in der Geld- und Fiskalpolitik sorgen und die Umsetzung der Regulierungsreformen vorantreiben. ... Full Article
2018 BIZ-Quartalsbericht, September 2018 By www.bis.org Published On :: 2018-09-23T16:00:00Z German translation of the BIS Quarterly Review, September 2018 Full Article
2018 BIZ-Quartalsbericht, Dezember 2018 By www.bis.org Published On :: 2018-12-16T17:00:00Z German translation of the BIS Quarterly Review, December 2018 Full Article
2018 Director's Update - Feb 2018 By feedproxy.google.com Published On :: Wed, 24 Jan 2018 19:19:46 +0000 OM Director's Update from Lawrence Tong, International Director Full Article
2018 Director's Update - Mar 2018 By feedproxy.google.com Published On :: Tue, 27 Feb 2018 14:58:21 +0000 OM Director's Update from Lawrence Tong, International Director Full Article
2018 Director's Update - Apr 2018 By feedproxy.google.com Published On :: Wed, 18 Apr 2018 13:17:46 +0000 OM Director's Update from Lawrence Tong, International Director Full Article
2018 Director's Update - May 2018 By feedproxy.google.com Published On :: Thu, 26 Apr 2018 18:02:36 +0000 OM Director's Update from Lawrence Tong, International Director Full Article
2018 Director's Update - June 2018 By feedproxy.google.com Published On :: Wed, 04 Jul 2018 15:24:02 +0000 OM Director's Update from Lawrence Tong, International Director. Full Article
2018 Director's Update - July 2018 By feedproxy.google.com Published On :: Wed, 04 Jul 2018 15:28:36 +0000 OM Director's Update from Lawrence Tong, International Director Full Article
2018 Director's Update - Sept 2018 By feedproxy.google.com Published On :: Sat, 25 Aug 2018 19:35:59 +0000 OM Update from Lawrence Tong, International Director Full Article
2018 Director's Update - Oct 2018 By feedproxy.google.com Published On :: Thu, 27 Sep 2018 19:16:26 +0000 OM Director's Update from Lawrence Tong, International Director Full Article
2018 Director's Update - Nov 2018 By feedproxy.google.com Published On :: Wed, 31 Oct 2018 19:33:18 +0000 OM Director's Update by Lawrence Tong, International DIrector Full Article
2018 Director's Update - Dec 2018 By feedproxy.google.com Published On :: Wed, 06 Mar 2019 13:22:43 +0000 OM Director's Update from Lawrence Tong Full Article
2018 The 2018 Apple iPad Is More Than $200 Off at Walmart By www.pcmag.com Published On :: The sixth-generation 9.7-inch iPad with 128GB of storage and cellular connectivity would normally set you back $559, but is currently marked down to just $349. Full Article
2018 2018/19 UEFA Regions' Cup qualifying draw By www.uefa.com Published On :: Wed, 06 Dec 2017 13:04:00 GMT Europe's top competition for amateur players returns for 2018/19 with 39 nations discovering the fate of their eventual representatives in the preliminary and intermediate round draws. Full Article general
2018 Women's Champions League Squad of the Season 2018/19 By www.uefa.com Published On :: Mon, 20 May 2019 12:00:00 GMT UEFA's technical observers have selected their all-star squad from the 2018/19 UEFA Women's Champions League. Full Article general
2018 FCCC/SBI/2018/3 By unfccc.int Published On :: Fri, 16 Feb 2018 15:41:39 +0100 Capacity-building work of bodies established under the Convention and its Kyoto Protocol. Compilation and synthesis report by the secretariat. Full Article
2018 FCCC/SBSTA/2018/3 By unfccc.int Published On :: Mon, 19 Feb 2018 11:48:46 +0100 Adaptation in human settlements: key findings and way forward. Report by the secretariat. Full Article
2018 FCCC/SBI/2018/1 By unfccc.int Published On :: Mon, 19 Feb 2018 16:24:17 +0100 Provisional agenda and annotations. Note by the Executive Secretary. Full Article
2018 FCCC/SBSTA/2018/1 By unfccc.int Published On :: Mon, 19 Feb 2018 17:16:55 +0100 Provisional agenda and annotations. Note by the Executive Secretary. Full Article
2018 FCCC/SBI/2018/2 By unfccc.int Published On :: Mon, 19 Feb 2018 17:51:20 +0100 Technical workshop on ways to increase the efficiency and transparency of the budget process. Report by the secretariat. Full Article
2018 FCCC/APA/2018/1 By unfccc.int Published On :: Tue, 27 Feb 2018 11:11:32 +0100 Agenda and annotations. Note by the Executive Secretary. Full Article
2018 FCCC/SBI/2018/3/Add.1 By unfccc.int Published On :: Tue, 13 Mar 2018 11:25:11 +0100 Capacity-building work of bodies established under the Convention and its Kyoto Protocol. Compilation and synthesis report by the secretariat. Addendum. Compilation of capacity-building activities undertaken by bodies established under the Convention and its Kyoto Protocol Full Article
2018 FCCC/SBI/2018/4 By unfccc.int Published On :: Thu, 15 Mar 2018 15:43:19 +0100 The 33rd meeting of the Least Developed Countries Expert Group. Report by the secretariat. Full Article
2018 FCCC/SBI/2018/5 By unfccc.int Published On :: Fri, 16 Mar 2018 14:55:50 +0100 Implementation of the framework for capacity-building in developing countries. Synthesis report by the secretariat. Full Article
2018 FCCC/SBI/2018/7 By unfccc.int Published On :: Thu, 22 Mar 2018 16:51:57 +0100 Arrangements for Intergovernmental Meetings. Note by the Executive Secretary. Full Article
2018 FCCC/SBSTA/2018/2 By unfccc.int Published On :: Mon, 26 Mar 2018 14:42:53 +0200 Outcomes of work under the Nairobi work programme on impacts, vulnerability and adaptation to climate change since May 2016. Synthesis report by the secretariat. Full Article
2018 FCCC/SBI/2018/INF.5 By unfccc.int Published On :: Mon, 09 Apr 2018 12:30:17 +0200 United Nations Environment Programme response to the independent review of the Climate Technology Centre and Network. Full Article
2018 FCCC/SBI/2018/INF.7 By unfccc.int Published On :: Mon, 09 Apr 2018 14:46:37 +0200 Status of submission and review of seventh national communications and third biennial reports. Note by the secretariat. Full Article
2018 Ceftobiprole Activity against Bacteria from Skin and Skin Structure Infections in the United States from 2016 through 2018 [Susceptibility] By aac.asm.org Published On :: 2020-03-16T08:17:36-07:00 Ceftobiprole medocaril is an advanced-generation cephalosporin prodrug that has qualified infectious disease product status granted by the US-FDA and is currently being evaluated in phase 3 clinical trials in patients with acute bacterial skin and skin structure infections (ABSSSIs) and in patients with Staphylococcus aureus bacteremia. In this study, the activity of ceftobiprole and comparators was evaluated against more than 7,300 clinical isolates collected in the United States from 2016 through 2018 from patients with skin and skin structure infections. The major species/pathogen groups were S. aureus (53%), Enterobacterales (23%), Pseudomonas aeruginosa (7%), β-hemolytic streptococci (6%), Enterococcus spp. (4%), and coagulase-negative staphylococci (2%). Ceftobiprole was highly active against S. aureus (MIC50/90, 0.5/1 mg/L; 99.7% susceptible by EUCAST criteria; 42% methicillin-resistant S. aureus [lsqb]MRSA[rsqb]). Ceftobiprole also exhibited potent activity against other Gram-positive cocci. The overall susceptibility of Enterobacterales to ceftobiprole was 84.8% (>99.0% susceptible for isolate subsets that exhibited a non-extended-spectrum β-lactamase [lsqb]ESBL[rsqb]-phenotype). A total of 74.4% of P. aeruginosa, 100% of β-hemolytic streptococci and coagulase-negative staphylococci, and 99.6% of Enterococcus faecalis isolates were inhibited by ceftobiprole at ≤4 mg/L. As expected, ceftobiprole was largely inactive against Enterobacterales that contained ESBL genes and Enterococcus faecium. Overall, ceftobiprole was highly active against most clinical isolates from the major Gram-positive and Gram-negative skin and skin structure pathogen groups collected at U.S. medical centers participating in the SENTRY Antimicrobial Surveillance Program during 2016–2018. The broad-spectrum activity of ceftobiprole, including potent activity against MRSA, supports its further evaluation for the potential ABSSSI indication. Full Article
2018 Pediatric Orphan Drug Indications: 2010-2018 By pediatrics.aappublications.org Published On :: 2020-04-01T01:00:57-07:00 BACKGROUND: Orphan drug development is crucial for children, who are disproportionately affected by rare diseases. Data are lacking on the number, nature, and benefit of recently approved pediatric orphan indications. METHODS: We classified the 402 orphan indications the US Food and Drug Administration approved between 2010 and 2018 as "pediatric" if they were approved for children only or targeted pediatric diseases. We determined the number of unique diseases targeted by pediatric orphan indications and calculated the proportion that were for (1) novel drugs, (2) non-novel drugs approved to treat ≥1 common disease, and (3) non-novel drugs approved only to treat rare diseases. Among pediatric orphan indications eligible for US Food and Drug Administration breakthrough designation (granted to drugs potentially representing major therapeutic advances), we calculated the proportion receiving this designation. RESULTS: Of the 402 orphan indications, 136 (33.8%) were pediatric. These 136 indications targeted 87 unique diseases; 21 diseases were targeted by ≥1 indication. Of the 136 pediatric orphan indications, 60 (44.1%) were for novel drugs, 45 (33.1%) were for non-novel drugs approved to treat ≥1 common disease, and 31 (22.8%) were for non-novel drugs approved only to treat rare diseases. Among 97 indications eligible for breakthrough designation, 20 (20.6%) received this designation. CONCLUSIONS: Recent orphan drug development has increased the availability of treatments for pediatric rare diseases. Most pediatric orphan indications expanded use of existing drugs, and many targeted the same disease. Some indications may represent breakthroughs, but substantial unmet need for treatments remains for most pediatric rare diseases. Full Article
2018 Volkswagen gives UEFA Futsal EURO 2018 wheels By www.uefa.com Published On :: Fri, 29 Sep 2017 10:30:00 GMT The 55-vehicle Volkswagen fleet which will transport players and officials at UEFA Futsal EURO 2018 has been handed over to the tournament organisers. Full Article general
2018 UEFA Futsal EURO 2018 finals draw made By www.uefa.com Published On :: Fri, 29 Sep 2017 11:51:00 GMT Hosts Slovenia have been handed a tough group with Italy and Serbia while France's debut finals match will be against holders Spain after the draw was made in Ljubljana. Full Article general
2018 UEFA Futsal EURO 2018: meet the teams By www.uefa.com Published On :: Mon, 29 Jan 2018 07:42:00 GMT We look at the 12 teams that will compete in Slovenia between 30 January and 10 February – from champions Spain and former winners Italy and Russia to debutants France. Full Article general
2018 Futsal EURO 2018: all you need to know By www.uefa.com Published On :: Tue, 30 Jan 2018 16:01:00 GMT UEFA Futsal EURO 2018 runs until 10 February in Ljubljana with 12 teams aiming for the title: we give you the key pointers to following a tournament full of skill and passion. Full Article general
2018 Where to watch UEFA Futsal EURO 2018 By www.uefa.com Published On :: Tue, 06 Feb 2018 21:41:00 GMT You can watch UEFA Futsal EURO 2018 across Europe and the world thanks to UEFA's broadcast partners and the live streaming of games on UEFA.com and our YouTube channel UEFA.tv. Full Article general
2018 UEFA Futsal EURO 2018 results, highlights By www.uefa.com Published On :: Sat, 10 Feb 2018 18:04:00 GMT See all the results and highlights from UEFA Futsal EURO 2018 at Ljubljana's Stožice Arena. Full Article general
2018 Futsal EURO 2018 team of the tournament By www.uefa.com Published On :: Wed, 14 Feb 2018 15:44:00 GMT Ricardinho, Taynan, Douglas Junior, Pola and Georgi Zamtaradze have been named the best five players of the 2018 finals and are also in the 14-strong selection for the Team of the Tournament. Full Article general
2018 2018/19 U19 EURO qualifying round draw made By www.uefa.com Published On :: Wed, 06 Dec 2017 08:03:00 GMT The 2018/19 UEFA European Under-19 Championship qualifying round draw has been made in Nyon, starting the road to the July 2019 finals in Armenia. Full Article general
2018 Amazon Kindle Paperwhite (2018) By www.pcmag.com Published On :: The waterproof Kindle Paperwhite offers more for your money than any other ebook reader on the market. Full Article
2018 Tallinn to stage 2018 UEFA Super Cup By www.uefa.com Published On :: Tue, 08 Aug 2017 19:45:00 GMT The 2018 UEFA Super Cup will be played on 15 August of next year at Tallinn's Lilleküla Stadium, the first senior UEFA final in Estonia in the centenary of that republic's creation. Full Article general
2018 All you need to know about the 2018 UEFA Super Cup By www.uefa.com Published On :: Mon, 13 Aug 2018 10:00:00 GMT Real Madrid will take on Atlético in Tallinn, Estonia, on Wednesday. Full Article general